NeoChord

Maple Grove, MN · Founded 2007 · Privately Held (backing)

Developer of an artificial chordae delivery system designed to resolve and restore normal mitral valve function. NeoChord is based in Maple Grove, MN and was founded in 2007. Its last reported valuation was $50 million in Jun 2015. It has raised $95.4 million across 13 recorded rounds; the latest was a $493,240 seed round in Feb 2025.

Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$95.4M
Last round
Seed Round
Feb 2025

Who backs NeoChord?

18 investors
InvestorType
Deerfield ManagementVenture capital
Mayo Clinic Ventures—
Baird CapitalPE / buyout
Andcor Companies—
CHV Capital—
Chris Wang—
Deerfield Capital—
Heron Capital—
Kyle Salyers—
Square 1 Bank—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NeoChord investors

18 investors are on record for NeoChord, including Deerfield Management, Mayo Clinic Ventures, Baird Capital and Andcor Companies. The seed round in Feb 2025 drew 14 investors.

Free account
More of NeoChord with a free account
  • ·The complete investor list: 18 names
  • ·Watch NeoChord: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like NeoChord. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View